ZLNA fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Zelluna ASA is a biotechnology company focused on developing innovative and cost-efficient therapies for advanced solid cancers. It develops “off-the-shelf” TCR-guided NK cell therapies (TCR-NK) to treat solid cancers, offering broad cancer detection and scalable treatment. The company is headquartered in Oslo, Norway.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
ZLNA has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company